主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

• 专科管理 • 上一篇    下一篇

结直肠癌患者口服化疗药依从性与健康信念相关性的研究

陈依琳 张美芬 覃惠英 吴晓丹 王霞   

  1. 浙江大学附属邵逸夫医院肛肠外科,310016 杭州市(陈依琳);中山大学护理学院(张美芬,王霞);中山大学肿瘤防治中心(覃惠美,吴晓丹)
  • 出版日期:2017-09-25 发布日期:2017-09-25
  • 基金资助:
    广东省财政厅产业技术研究与开发基金(131171)

Relationship between oral chemotherapy adherence and health belief in colorectal cancer patients

  • Online:2017-09-25 Published:2017-09-25

摘要: 目的:探讨化疗不同时期结直肠癌患者口服化疗药依从性与健康信念的相关性,以期为临床实践中提高结直肠癌患者口服化疗药依从性提供依据。方法:本研究为前瞻性纵向研究,采用便利抽样的方法,运用Morisky药物依从性量表、Champion健康信念模式量表对132例结直肠癌口服化疗药患者进行问卷调查。结果:化疗早、中期,口服化疗药依从性与感知到的严重性呈负相关(P<0.01),与感知到的益处呈正相关(P<0.05);化疗晚期,依从性与感知到的障碍维度呈正相关(P<0.01)。结论:患者感知到疾病越严重、治疗的益处越小、治疗的障碍越大,依从性越差,医务人员应帮助患者正确认识自身疾病以及治疗对疾病的益处,使患者树立疾病治疗和健康的信心,从而提高患者的口服化疗药依从性。

Abstract: Objective: The purpose of this study was to explore the relationship between oral chemotherapy adherence and health belief among colorectal cancer patient at different stages of chemotherapy, in order to provide evidence to improve colorectal cancer patients' oral chemotherapy adherence. Methods: This was a prospective study, a descriptive, follow-up design was used in this study. By convenient sampling, totally 132 cases of colorectal cancer patients were collected. The survey investigated general information, oral chemotherapy adherence and health belief by structured questionnaires. Results: In the early and middle stage of chemotherapy, oral chemotherapy adherence was negatively correlated with perceived severity (P<0.01), positively correlated with perceived benefits (P<0.05). In late stage of chemotherapy, oral chemotherapy adherence was positively correlated with perceived barriers (P<0.01). Conclusion: In the early and middle stage of chemotherapy, the more serious patients perceived of the disease, the less benefit they got from treatment, and the more non-adherences they would have. In the late stage of chemotherapy, the more barriers patients perceived during the treatment, the more non-adherences they would have. Nurses should help patients address the benefit of treatment, help them build confidence of treatment and health, and improve patients' adherence to oral chemotherapy.